RARA CRAFT DATABASE for FDA Medical Devices
510(k)K222076

FDA DEVICE FACTS

EFAI ChestSuite XR Pleural Effusion Assessment System

Ever Fortune.Ai, Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

AI/ML
DECISION DATESeptember 8, 2022PRODUCT CODEQFMCLINICAL AREARadiology

Indications for use

EFAI Chestsuite XR Pleural Effusion Assessment System is a software workflow tool designed to aid the c linical assessment of adult (18 years of age or older) Chest X -Ray cases with features suggestive of pleural effusion in the medical care environment. EFAI Chestsuite XR Pleural Effusion Assessment System analyzes cases using an artificial intelligence a lgorithm to identify suspected findings on chest x-ray images taken in PA position. It makes case-level output available to a PACS/workstation for worklist prioritization or triage. EFAI Chestsuite XR Pleural Effusion Assessment System is not intended to direct attention to specific portions or anomalies of an image. Its results are not intended to be used on a stand-alone basis for clinical decision-making nor is it intended to rule out pleural effusion or otherwise preclude clinical assessment of X-Ray cases.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 16, 2026